Clinical Trial Results

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

PHASE1INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

Genes and Environment in Multiple Sclerosis

N/AOBSERVATIONAL Bethesda, Maryland +4 more

RECRUITING

Eccentric Exercise and Fatigue in Multiple Sclerosis

N/AOBSERVATIONAL New York, New York

RECRUITING

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

PHASE1INTERVENTIONAL La Jolla, California +4 more

RECRUITING

A Palliative Care Model Impact on Knowledge and Attitudes

NAINTERVENTIONAL New York, New York +1 more

RECRUITING

Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)

PHASE2INTERVENTIONAL New York, New York

RECRUITING

A Study of the MIND Diet for Persons With Multiple Sclerosis

NAINTERVENTIONAL New York, New York

RECRUITING

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

PHASE2INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

PHASE1INTERVENTIONAL Tucson, Arizona +4 more

RECRUITING

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

PHASE3INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment

PHASE1INTERVENTIONAL Newport Beach, California +4 more

RECRUITING

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

PHASE1, PHASE2INTERVENTIONAL La Jolla, California +4 more

RECRUITING

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

PHASE2INTERVENTIONAL Baltimore, Maryland +1 more

RECRUITING

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

PHASE3INTERVENTIONAL Palo Alto, California +4 more

RECRUITING

Vancomycin Study in Multiple Sclerosis (MS)

PHASE1INTERVENTIONAL New York, New York

RECRUITING

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders

N/AOBSERVATIONAL New York, New York

RECRUITING

Effect of Cooling on Balance Performance in Multiple Sclerosis

N/AOBSERVATIONAL New York, New York

RECRUITING

NYSCF Scientific Discovery Biobank

N/AOBSERVATIONAL New York, New York

RECRUITING

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

N/AOBSERVATIONAL Birmingham, Alabama +4 more

RECRUITING

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more

RECRUITING

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

PHASE3INTERVENTIONAL Cullman, Alabama +4 more

RECRUITING

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

PHASE3INTERVENTIONAL Loma Linda, California +4 more

RECRUITING

Gait Adaptation Study

EARLY_PHASE1INTERVENTIONAL Newark, New Jersey

RECRUITING

Neurologic Stem Cell Treatment Study

NAINTERVENTIONAL Westport, Connecticut +2 more

RECRUITING